#2195 - Andrew Huberman

6680.889 - 6698.979 Guest

And frankly, there may be something to it, right? I mean, now we're hearing all about microplastics. We're hearing about all that. But when it comes to the GLP-1 agonist, right? I spent a lot of time on this, done two podcasts or more, one with an expert, one solo, et cetera. You know, of all the peptides that broke through, you know, we've talked about peptides, we've talked about more.